[Editor’s Note: As the decade comes to an end, we’ve asked a number of Xconomists around the country to weigh in with the Top 5 innovations they’ve seen in their respective fields the past 10 years, or the Top 5 disruptive technologies that will impact the next decade. Here’s the first installment.]
Here are the 5 biotech innovations from this decade that are currently (or will be shortly) making a big difference for patients with a variety of diseases.
1) Cancer therapies such as Roche/Genentech’s trastuzumab (Herceptin) and Celgene’s lenalidomide (Revlimid).
2) HIV therapies such as Gilead Sciences’ combination of efavirenz, emtricitabine, and tenofovir (Atripla).
3) Improved flu vaccines.
4) Therapies for hepatitis C such as Vertex Pharmaceuticals’ telaprevir.
5) Tumor vaccines such as Dendreon’s sipuleucel-T (Provenge).
By posting a comment, you agree to our terms and conditions.